Polypharmacy is common in older adults and is associated with adverse drug events, cognitive and functional impairment, and increased healthcare costs. What do we know about the effectiveness of deprescribing interventions? bmj.com/content/385/bm…

How can #USDEN24 already be over? 🥹 I had an amazing time today😍

Interested in connecting with deprescribers from across the world? 💊🌍 🚨 Don't miss out and register today! 🚨 Can't wait to see fellow deprescribers at #ICOD2 in Nantes! 🤩

A New Deprescribing Study Shows Impact of the EMPOWER Brochure in the US: 26% of patients who received an educational brochure (adapted version of the EMPOWER brochure), physician letter & flyer on benzodiazepine risks discontinued their benzos at 9 months, vs 17% in the

🚨 Delighted to see the publication of our survey on community pharmacists' awareness, identification, and management of prescribing cascades - which has emphasised that pharmacists want ⬆️ info & resources to help them identify and manage them in practice tinyurl.com/yc4fxkk2

🚨 Our new paper published in International Journal of Clinical Pharmacy shows that #patient-centred #medication reviews by #pharmacists in general practice settings produce substantial savings 💶 💊 These roles should be considered for wider implementation (in #Ireland & beyond) tinyurl.com/5e9nuknt

Deprescribers, register for the incoming ICOD2! 🇫🇷 💊

💊#USDeN Featured #Research Article: "Measuring #QualityOfLife in #Deprescribing Trials" from Wade Thompson et al. Read it here➡️: link.springer.com/article/10.100…

How different levels of cognition affect medication management and patient outcomes? Check out our most recent work at: journals.sagepub.com/doi/10.1177/07…

Large Systematic Review of 286 papers led by Hui Wen Quek evaluates the impact of #deprescribing in older adults. 🚨 Significant mortality reduction was seen in select groups & intervention-types: buff.ly/3XdFrnu Amy Page Kenneth Lee Debbie Hawthorne Australian Deprescribing Network (ADeN)

New study led by Ｋａｔｈａｒｉｎａ Ｊｕｎｇｏ Once an older adult starts a high-risk medication, what factors make them more likely to become chronic users? Turns out it's complicated, but here we break it down by high-risk medication class 👇 #MedTwitter pubmed.ncbi.nlm.nih.gov/39215549/